The health disparities of uterine fibroid tumors for African American women: a public health issue
about
Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysisLeiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional culturesEffects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal womenRole of vitamin D in uterine fibroid biologySex Differences Research, Precision Medicine, and the Future of Women's Health.MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma.Endocrine-disrupting chemicals and uterine fibroids.Uterine fibroid management: from the present to the future.Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis.Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.Prevalent Health Concerns Among African American Women Belonging to a National Volunteer Service Organization (The Links, Incorporated).An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.Racial/Ethnic Differences in Women's Experiences with Symptomatic Uterine Fibroids: a Qualitative Assessment.Race-based disparities in loss of functional independence after hysterectomy for uterine cancer.
P2860
Q26781819-1B06B3C3-B6E4-4719-AAB2-F52BD9E5E1BAQ33812716-F99F91D8-F382-4951-87A2-18A167338137Q34418138-5C20054C-B794-4516-866A-C428470A4504Q35798666-42AD4223-34CF-406F-A117-8408B8916FD7Q36030956-4A22E6C8-816F-46FA-857D-24B73D0E1BEDQ36382878-E6CEB256-C1B6-4795-85AC-BA94DC923978Q37182392-092B8109-0323-4A83-89D8-DE0153974F1FQ38828590-E1E9F0E2-F14B-49ED-BD8E-F59C99CA23CFQ38837038-19BBD7FB-609C-466A-8081-6BC170CC8183Q39292947-12FFB24C-12A6-4FBE-9E74-2B4297DC4071Q39637393-A0ACC16C-39F1-46D5-B4EB-05E23785D144Q39688316-8D3F55E6-AC5E-4302-A543-75793C0E8C66Q39753788-D680C846-09D7-4AA4-820A-0A7335245D38Q39855034-3E9F3412-BD03-48AE-B476-85B9D95CAB0DQ39858894-D7A13DDD-334D-4306-BB65-06DDA36D7AA7Q40828446-6B670BAA-5F85-4F34-B5B3-6543BC68E7CD
P2860
The health disparities of uterine fibroid tumors for African American women: a public health issue
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The health disparities of uter ...... n women: a public health issue
@en
The health disparities of uter ...... women: a public health issue.
@nl
type
label
The health disparities of uter ...... n women: a public health issue
@en
The health disparities of uter ...... women: a public health issue.
@nl
prefLabel
The health disparities of uter ...... n women: a public health issue
@en
The health disparities of uter ...... women: a public health issue.
@nl
P2093
P2860
P1476
The health disparities of uter ...... n women: a public health issue
@en
P2093
Alicia Y Armstrong
Heba M Eltoukhi
Meredith Weston
Monica N Modi
P2860
P304
P356
10.1016/J.AJOG.2013.08.008
P407
P577
2013-08-11T00:00:00Z